$2.50
-0.10-4.04%
Last update: Oct 28, 1:06 PM
PepGen Inc (PEPG) Stock Price, Quote, News & History
PEPGNASDAQ
Undervalued companies in health care sector with low RSI values present buying opportunity: PepGen Inc (PEPG), KALA BIO Inc (KALA), Viridian Therapeutics Inc...
You can purchase shares of PepGen (NASDAQ:PEPG) through any online brokerage.
Other companies in PepGen’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
PepGen has a consensus price target of $10.00.
The stock price for PepGen (NASDAQ: PEPG) is $2.495 last updated October 28, 2026 at 1:06 PM EDT.
There are no upcoming dividends for PepGen.
PepGen does not have any upcoming earnings scheduled.
There is no upcoming split for PepGen.
PepGen is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery...
